PBLA - Panbela Therapeutics GAAP EPS of -$0.65 May, 04 2023 04:56 PM Panbela Therapeutics Inc Com 2023-05-04 16:56:27 ET Panbela Therapeutics press release ( NASDAQ: PBLA ): Q1 GAAP EPS of -$0.65. Shares -8.9% . Total cash was $5.2 million as of March 31, 2023. For further details see: Panbela Therapeutics GAAP EPS of -$0.65